APP and Seizure: Seizure risk is higher in patients with autosomal dominant AD: a seizure frequency of 47.7%, after mean follow up of 8.4 years was found in AD patients harbouring a pathogenic PSEN1, PSEN2, APP mutation or a duplication of APP [16].